STOCKWATCH
·
Biological Products, (No Diagnostic Substances)
AcquisitionsApr 13, 2026, 09:31 AM

BiomX Acquires 60% Stake in DR. Frucht Systems for $3.75M + Shares

AI Summary

BiomX Inc. has completed the acquisition of a 60% fully diluted equity stake in DR. Frucht Systems Ltd. (DFSL) by exercising its option with Mandragola Ltd. The consideration for the acquisition included a cash payment of $750,000, a $3 million convertible promissory note, and the issuance of 923,000 shares of BiomX common stock. This transaction expands BiomX's portfolio by integrating DFSL.

Key Highlights

  • Acquired 60% fully diluted equity in DR. Frucht Systems Ltd.
  • Paid $750,000 in cash, with $450,000 already advanced.
  • Issued a $3,000,000 convertible note at $12.00 per share.
  • Issued 923,000 shares of BiomX common stock.
PHGE
Biological Products, (No Diagnostic Substances)
BiomX Inc.

Price Impact